Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the USA.
| Product | Description | |
|---|---|---|
| 3-Deoxy-3-acetyl abiraterone-3-ene | An impurity of Abiraterone. Abiraterone acetate is a CYP17A1 inhibitor and by extension androgen synthesis inhibitor. In combination with prednisone, it is indicated for the treatment of patients with metastatic castration-resistant prostate cancer who have already received prior chemotherapy containing docetaxel under the trade name Zytiga. Group: Pharmaceutical. Pack Sizes: 10 mg. Product ID: B0038-007224. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| 3-Deoxy 3-chloroabiraterone | An impurity of Abiraterone. Abiraterone acetate is a CYP17A1 inhibitor and by extension androgen synthesis inhibitor. In combination with prednisone, it is indicated for the treatment of patients with metastatic castration-resistant prostate cancer who have already received prior chemotherapy containing docetaxel under the trade name Zytiga. Group: Pharmaceutical. Pack Sizes: 10 mg. Product ID: B0038-007226. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Abiraterone | Abiraterone blocks the synthesis of androgens by inhibiting CYP17A1. It is used to treat metastatic, castration-resistant prostate cancer. Uses: The treatment of metastatic, castration-resistant prostate cancer. Group: Pharmaceutical. CAS No. 154229-19-3. Pack Sizes: 5 g. Product ID: B0084-059670. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Abiraterone acetate | The acetate form of abiraterone, which blocks the synthesis of androgens by inhibiting CYP17A1. It can be used to treat metastatic, castration-resistant prostate cancer. Uses: The treatment of metastatic, castration-resistant prostate cancer. Group: Pharmaceutical. CAS No. 154229-18-2. Pack Sizes: 10 g. Product ID: NP3330. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Abiraterone Acetate-[d4] | Abiraterone Acetate-[d4] is a labelled form of Abiraterone Acetate, the acetate form of abiraterone, which blocks the synthesis of androgens by inhibiting CYP17A1. This compound is also useful in kinetic isotope effect studies as well as for use as an internal standard in NMR experiments. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BLP-003182. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Abiraterone Acetate Impurities | Abiraterone Acetate Impurities play a vital role in the biomedical industry, specifically in ensuring the safety and efficacy of abiraterone, a drug used to treat metastatic castration-resistant prostate cancer. Monitoring these impurities is critical to maintaining the pharmaceutical quality of abiraterone formulations, thereby safeguarding therapeutic outcomes. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Abiraterone-[d4] | Abiraterone-[d4] is a labelled Abiraterone. Abiraterone is a steroidal CYP17A1 inhibitor with a therapeutic effect on androgen-dependent prostate cancer. Group: Pharmaceutical. CAS No. 2122245-62-7. Pack Sizes: 1mg; 1g; 10g. Product ID: BLP-003183. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Abiraterone Ethyl Ether-[d5] | Abiraterone Ethyl Ether-[d5] is the labelled impurity of Abiraterone. Abiraterone blocks the synthesis of androgens by inhibiting CYP17A1. It is used to treat metastatic, castration-resistant prostate cancer. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BLP-003184. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Abiraterone Isopropyl Ether-[d7] | Abiraterone Isopropyl Ether-[d7] is the labelled impurity of Abiraterone. Abiraterone blocks the synthesis of androgens by inhibiting CYP17A1. It is used to treat metastatic, castration-resistant prostate cancer. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BLP-003185. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Anhydro abiraterone | An impurity of Abiraterone. Abiraterone acetate is a CYP17A1 inhibitor and by extension androgen synthesis inhibitor. In combination with prednisone, it is indicated for the treatment of patients with metastatic castration-resistant prostate cancer who have already received prior chemotherapy containing docetaxel under the trade name Zytiga. Group: Pharmaceutical. CAS No. 154229-20-6. Pack Sizes: 10 mg. Product ID: B0038-007225. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 16-Dehydropregnenolone acetate | 16-Dehydropregnenolone acetate is an impurity of Abiraterone, which is a CYP17A1 inhibitor and by extension androgen synthesis inhibitor. In combination with prednisone, it is indicated for the treatment of patients with metastatic castration-resistant prostate cancer who have already received prior chemotherapy containing docetaxel under the trade name Zytiga. Group: Pharmaceutical. CAS No. 979-02-2. Pack Sizes: 25 g. Product ID: NP6241. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Our database is helping our users find suppliers everyday.
